Business
from24/7 Wall St.
5 days agoGuggenheim Raises AstraZeneca Price Target Ahead of Q1 Earnings
AstraZeneca's stock has increased 31.43% over the past year, with a price target of 16,500 GBp set by Guggenheim analyst Seamus Fernandez.
We are seeing a structural shift toward bundled deals. Both agreements include bundled mortgage and closing products, which the company said are incrementally accretive to unit economics. Our overall pipeline remains robust, up approximately 40% year over year.
He joins Blend after roles at Alkami Technology and ACI Worldwide, where he built sales teams and grew customer bases across community banks, credit unions and regional institutions. Blend has built a powerful platform, strong relationships with key customers, and has good momentum in the market, Thomson said in a statement. Financial institutions are looking for partners who can help them compete digitally while maintaining the relationships that define their brands.